About Us

Committed to speeding innovation for science-driven organizations, from product ideation through commercialization.


Visit us at the Biologics Congress

Conference Website

Event Date

1-2 February, 2016

Event Location

Berlin, Germany

Hear Us Present

Dr. Ranjeeva Ranasinghe, Business Consultant at GSK Medicines Research Centre, will be giving the following presentation on our behalf entitled 'Biological Registration – The growth of Biologicals at GSK’.

When: Monday, 1 February @ 10.00 - 10.30


In the past 10 years, Biologicals have become an increasingly critical part of the GSK R&D pipeline.  Biological entities span medicinal assets such as antibodies to the plethora of reagents used in their candidate selection.  Importantly, Biopharmaceutical assets have grown from <3% of GSK’s pipeline in 2008 to >25% in 2015. Being able to uniquely identify these entities and ensuring their traceability during the candidate selection process poses significant challenges.  Furthermore, increased collaboration with external parties, and compliance with up and coming regulatory obligations to ensure data integrity have increased the need for a robust Biological registration solution. GSK addressed these challenged by implementing the BIOVIA product as a cornerstone of GSKs registration strategy, which seamlessly complements the existing small molecule chemical registry. It also integrates upstream data loading systems and downstream inventory systems to simplify end-to-end inventory and ordering. In this talk, we will share the GSK experience with implementation of the Biological Registration solution.

Complimentary Passes

We have a limited number of complimentary passes to give away. For further information, please email adele.willacy@3ds.com

We look forward to seeing you in Berlin!

Browse By: